Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies.
about
Recent advances in amyotrophic lateral sclerosisQuo vadis motor neuron disease?The Use of Stem Cells to Model Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: From Basic Research to Regenerative MedicineAdducin at the Neuromuscular Junction in Amyotrophic Lateral Sclerosis: Hanging on for Dear LifeEmerging Roles of Filopodia and Dendritic Spines in Motoneuron Plasticity during Development and DiseaseA comprehensive review of amyotrophic lateral sclerosisBrain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?iPSC-Based Models to Unravel Key Pathogenetic Processes Underlying Motor Neuron Disease DevelopmentINaP selective inhibition reverts precocious inter- and motorneurons hyperexcitability in the Sod1-G93R zebrafish ALS modelEmerging mechanisms of molecular pathology in ALSPrion-like Mechanism in Amyotrophic Lateral Sclerosis: are Protein Aggregates the Key?Ubiquilin-2 drives NF-κB activity and cytosolic TDP-43 aggregation in neuronal cells.Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?Ataxin-2: From RNA Control to Human Health and DiseaseAberrant RNA homeostasis in amyotrophic lateral sclerosis: potential for new therapeutic targets?Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.Identifying the primary site of pathogenesis in amyotrophic lateral sclerosis - vulnerability of lower motor neurons to proximal excitotoxicity.Elevated mRNA-levels of distinct mitochondrial and plasma membrane Ca(2+) transporters in individual hypoglossal motor neurons of endstage SOD1 transgenic mice.Overexpression of α-synuclein in oligodendrocytes does not increase susceptibility to focal striatal excitotoxicity.Tertiary Amine Pyrazolones and Their Salts as Inhibitors of Mutant Superoxide Dismutase 1-Dependent Protein Aggregation for the Treatment of Amyotrophic Lateral Sclerosis.Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.Flecainide in Amyotrophic Lateral Sclerosis as a Neuroprotective Strategy (FANS): A Randomized Placebo-Controlled Trial.Cortical Function in Asymptomatic Carriers and Patients With C9orf72 Amyotrophic Lateral SclerosisADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosisActions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.Cortical synaptic and dendritic spine abnormalities in a presymptomatic TDP-43 model of amyotrophic lateral sclerosis.miRNAs: Key Players in Neurodegenerative Disorders and EpilepsyM1 and M2 Functional Imprinting of Primary Microglia: Role of P2X7 Activation and miR-125b.Rho Kinase Inhibition with Fasudil in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis-Symptomatic Treatment Potential after Disease Onset.ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem Cells and Extracellular VesiclesStem Cells in Neurological Disorders: Emerging Therapy with Stunning Hopes.Motor neuron disease-frontotemporal dementia: a clinical continuum.Next generation transcriptomics and genomics elucidate biological complexity of microglia in health and disease.Motor neuron disease: current management and future prospects.Immune-mediated processes in neurodegeneration: where do we stand?ADAMTS-4 in central nervous system pathologies.Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease.Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection.Further development of biomarkers in amyotrophic lateral sclerosis.Rate of disease progression: a prognostic biomarker in ALS.
P2860
Q26749521-A07EFD71-DD45-4349-AD5D-C52D0673F2E2Q26750561-97C7E69D-B1CC-4F68-A58E-845E2985F409Q26766372-857123F4-7AB7-40E5-A86B-A6DA5C7EE867Q26767792-ADC69956-10B8-4631-9CB3-09682129B38EQ26769059-FE4D7D65-CFB2-4B40-BEDE-229662C33858Q26775401-B599C9F6-6763-4288-9AC7-3F744E6741CFQ26799233-86986FAE-DC0E-455B-85C1-96795D40DA45Q26863612-18646EA3-569D-4B0C-BC9D-5B3EB0D3CF19Q27321452-7E19511B-9D60-47E3-8170-AC30C72B47AFQ28081239-C5D0918A-D9EC-405E-AAC4-2AFA137492D7Q28087798-3F9F0E0D-F91B-4A4C-AAE7-F2E286E0C5F8Q30671325-538FF599-FE7F-4D73-836F-36240D2CBCBEQ33582007-E40A8530-DB59-4654-AE10-851CEA634048Q33836795-118E63CD-621A-44EF-92F6-80A8FE9A063AQ35019375-B813AD2A-BF35-488C-A808-5FC423051FC4Q35068792-683D4DD7-C83C-46E8-83B5-3D809E820914Q35144020-2AA4DB3D-AA3F-4335-AFEB-753362E1DB4BQ35469175-3311E2B3-C0E4-450F-8E85-BD02E907ECFDQ35857994-775BED55-DA2C-4807-88D0-8017733DE113Q35956262-486B7C94-29E4-4E40-B6A9-BC43150F5A88Q35986943-E70B5D7C-5E17-46A8-BBA2-3B31B974166CQ36437641-67F060E0-FC1C-4372-8F51-3F0E253E391DQ36447450-64623534-DAC9-447F-B3FC-26157720A648Q36503572-56C90385-7F58-4931-86EB-8B54DBC6DE70Q37196234-3945DD1F-3DC9-4D66-8E7A-14E3F5C574AEQ37449093-7690B80B-2CA0-429B-9AFC-0A4A9B4796F7Q37535111-B0D3A9A7-733D-4C7F-9999-6E696A00E324Q37549540-68816623-511C-427C-9E6E-FE4C45C8E5F8Q37614522-1E5EA560-DAAB-4802-94A9-E2C72DB9DE37Q37712624-95E15D8A-FECB-4F3A-BEAC-09984DD122B0Q38252939-A7DD837D-993C-4D48-9E99-60D35599ACC4Q38417288-8B6EE9FA-8259-4F8C-BF19-065312EE4966Q38514940-EB4B7B5F-7DA2-41F1-8D6F-33E797209F86Q38597450-FB06F482-FF23-49AD-95DE-432E46E3C96EQ38731476-FEADF75B-DA91-4CBB-8418-E120B98DB142Q38770884-278CA6F2-6C56-4320-B237-AA77A51D607FQ38796845-86FDA514-CCF2-478F-AFDF-76664E99486CQ38847200-F044CCF0-4567-40EC-8905-D46E55A9F2DBQ38856405-08709B44-7D7A-4915-9F22-F93BAC54C319Q38987413-50A4FBB0-865D-4393-B612-EDA512519D86
P2860
Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Advances in treating amyotroph ...... om pathophysiological studies.
@en
type
label
Advances in treating amyotroph ...... om pathophysiological studies.
@en
prefLabel
Advances in treating amyotroph ...... om pathophysiological studies.
@en
P1476
Advances in treating amyotroph ...... om pathophysiological studies.
@en
P2093
Jeffrey D Rothstein
P304
P356
10.1016/J.TINS.2014.05.006
P577
2014-06-11T00:00:00Z